MEGGLE brings InhaLac® 500 to CPhI Worldwide
Press Release | MEGGLE Excipients & Technology
OCTOBER 09, 2017
Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Excipients & Technology (MEGGLE) will return as an exhibitor to the CPhI Worldwide expo in Frankfurt with an expanded range of lactose-based pharmaceutical excipients.
MEGGLE is one of CPhI’s most established exhibitors, having attended every worldwide expo for more than 20 years, almost since the event was initially founded in 1991.
“Once again we will be taking advantage of this exhibition to reach out to our important existing and potential business partners and to present our product portfolio, now significantly enhanced with the addition of our latest product InhaLac® 500,” said Christoph Adler, Area Manager & Project Manager Marketing.
The experts of MEGGLE are looking forward welcome you on the MEGGLE stand 11.OF32.
High cohesion and stability
Developed at MEGGLE’s Wasserburg laboratories in Germany, InhaLac 500 is MEGGLE´s first micronized lactose grade, specifically designed for inhalation with extremely small particles. Combined with high quality and safety, it meets the most demanding individual dry powder inhalation formulation requirements.
The micronization process used for InhaLac® 500 produces very small particles, high cohesive properties and even distribution, with 90% of the particles being smaller than 10 μm.
InhaLac® 500 exhibits a similar size as active pharmaceutical ingredients (APIs). This makes it very versatile across a wide range of applications
In summary, InhaLac 500 offers a potent range of overall benefits:
- Improvement of fine particle fractions (FPF) when used in ternary mixtures
- saturation of active sites
- co-agglomeration with drug particles etc.
- x90 less than 10 µm
- Highly Cohesive
- High stability
Once again, MEGGLE’s stand will be instantly recognizable for its ‘moss-covered’ look, symbolizing the company’s core values of sustainability, tradition and innovation. As with the previous stand at CPhI 2016 in Barcelona, the stand will combine a showcase of the company’s product portfolio with a comfortable area to host face-to-face meetings.
MEGGLE is currently accepting bookings for meetings during CPhI Worldwide.
About MEGGLE Wasserburg
Bavarian-based MEGGLE Wasserburg is one of the world’s experts in lactose based excipients and powder technology.
From its roots as a dairy operation in the late 1880s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.
MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.
A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage form applications, where they can deliver maximum performance.
The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compressible co-processed excipient using a hypromellose-lactose base for modified release formulations.
About CPhI Worldwide 2017
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors networking opportunities with potential international pharmaceutical partners and collaborators, as well as latest industry insights.
Now in its 28th year, CPhI 2017 is a three-day event opening October 24 at the Messe Frankfurt exhibition center. Last year’s event in Barcelona attracted some 42,000 delegates and more than 2,500 exhibitor companies from 155 countries worldwide.
CPhI Worldwide is held alongside four other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment, InnoPack pharmaceutical packaging and a new addition, the FDF show for Finished Dosage & Formulations, bringing together every aspect of the finished dosage supply chain.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: http://www.cphi.com/europe/
Margit Bonnetsmüller, Project Manager Marketing, MEGGLE Excipients &Technology Business Group
Tel: +49 8071 73 476